• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Can TMS Turn on the Switch?

Can TMS Turn on the Switch?

June 1, 2022
Edmund S. Higgins, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Edmund S. Higgins, MD. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Miuli A et al, World J Psychiatry 2021;11(8):477–490

STUDY TYPE: Literature review and meta-analysis

Some treatments for depression, particularly antidepressants, present risk of manic reactions, but whether this risk exists with transcranial magnetic stimulation (TMS) is less clear.

A group in Italy searched the world’s literature for studies using TMS for mood disorders. They sought studies that were double blind or single blind and published in English to find reports of manic and hypomanic switching.

The authors found 25 studies (21 double blind and four single blind) with a total of 576 subjects in active treatment and 487 receiving sham treatment. The studies used a variety of TMS protocols, but the most common was administered over the left dorsolateral prefrontal cortex for two weeks at 10 Hz with 2000–3000 pulses per session. Only eight studies reported on adverse effects like manic switching. Of those, four reported manic or hypomanic switches—three in active treatment and one in sham. Although there was a trend toward switches, the difference was not statistically significant, leading the authors to conclude that TMS does not seem to increase the risk of these reactions.

The parameters of TMS can be opaque to those of us who are not fluent in electricity, so we sought out Mark S. George, MD, one of the founding fathers of TMS (George MS et al, Neuroreport 1995;6(14):1853–1856) and editor-in-chief of the journal Brain Stimulation. Dr. George was hesitant to embrace the authors’ conclusion from this analysis.

He noted that the usual length of treatment is four to six weeks, so the majority of the studies reviewed here were underdosed at only two weeks. Furthermore, many of the studies used a gentler form of TMS with low-intensity pulses. More recent TMS protocols have raised the frequency of the magnetic pulse to produce faster results, a change that—in theory—could also raise the risk of mania.

CARLAT TAKE

This study provides some reassurance that TMS does not cause manic switching. However, many of the studies were underdosed, and few systematically looked for side effects. For all intents and purposes, this analysis does not answer the question.

General Psychiatry
KEYWORDS depression tms transcranial magnetic stimulation treatment-resistant-depression
    Edmund S. Higgins, MD.

    Stranger to Ourselves

    More from this author
    www.thecarlatreport.com
    Issue Date: June 1, 2022
    SUBSCRIBE NOW
    Table Of Contents
    Quetiapine Reconsidered
    Psychosis During Depression
    Can TMS Turn on the Switch?
    Uncommon Tips: Which Is Better—Citalopram or Escitalopram?
    Benzodiazepines: A Reevaluation of Their Benefits and Dangers
    How Essential Is Antidepressant Continuation?
    Hypothyroidism and Depression: Just How Related Are They?
    Topiramate Improves Weight in Schizophrenia in South Asians
    CME Post-Test - Psychotic Depression, TCPR, June/July 2022
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.